Skip to main content

Table 1 Performance of RQPCR by consensus germline or entirely patient-specific primers/probes

From: High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes

Cases

Consensus germline primers/probes

Patient-specific primers/probes

Diagnostic marrow DNA as standards

Diagnostic marrow DNA as standards

CDR3-cloned plasmid as standards

Sensitivity

QR

R 2

Slope

Sensitivity

QR

R 2

Slope

Sensitivity

QR

R 2

Slope

Dx53

N/A

10−2

N/A

N/A

10−5

10−4

0.996

−3.30

10−5

10−4

0.992

−3.44

M3

ND

ND

ND

ND

5 × 10−4

5 × 10−4

0.989

−3.48

10−4

10−4

0.997

−3.54

M8

10−4

5 × 10−4

0.985

−3.38

10−4

10−3

0.999

−3.46

10−4

5 × 10−4

0.999

−3.61

M4

ND

ND

ND

ND

10−4

10−3

0.984

−3.60

10−5

10−3

0.999

−3.54

Dx31

ND

ND

ND

ND

10−4

5 × 10−4

0.998

−3.45

10−4

10−4

0.998

−3.47

M5

10−4

10−4

0.995

−3.41

5 × 10−4

5 × 10−4

0.995

−3.67

10−5

10−4

0.998

−3.51

M10

N/A

5 × 10−4

N/A

N/A

N/A

5 × 10−4

N/A

N/A

10−4

10−4

0.994

−3.51

Dx49

5 × 10−4

10−3

0.982

−3.37

10−4

10−3

0.986

−3.26

10−4

5 × 10−4

0.999

−3.76

M1

ND

ND

ND

ND

5 × 10−4

10−3

0.986

−3.48

10−4

5 × 10−4

0.998

−3.52

M6

ND

ND

ND

ND

N/A

5 × 10−4

N/A

N/A

10−5

5 × 10−4

0.997

−3.72

M2

N/A

N/A

N/A

N/A

ND

ND

ND

ND

ND

ND

ND

ND

M7

N/A

10−2

N/A

N/A

N/A

10−2

N/A

N/A

10−4

10−3

0.999

−3.56

M9

N/A

10−2

N/A

N/A

N/A

10−2

N/A

N/A

10−4

10−4

0.997

−3.55

  1. Abbreviations: QR quantitative range, R 2 correlation coefficient, N/A not applicable, ND not done due to absence of target band in qualitative PCR or no need (for M2 in patient-specific approach)